Oracle’s (ORCL) shares dropped about 4% early Monday following a research note from TD Cowen that the software giant may axe up to 30,000 roles and sell its health tech unit Oracle Health. This comes even as the company disclosed plans to raise between $45 and $50 billion this year from debt and equity financing to fund its push into AI data centers.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

